We describe phaeochromocytoma (phaeo) penetrance in multiple endocrine neoplasia type 2 (MEN2) according to RET protooncogene‐specific mutations and report changes in phaeo diagnosis and management from 1968 to 2015. Click to show full abstract
We describe phaeochromocytoma (phaeo) penetrance in multiple endocrine neoplasia type 2 (MEN2) according to RET protooncogene‐specific mutations and report changes in phaeo diagnosis and management from 1968 to 2015.
               
Click one of the above tabs to view related content.